Investors

Home » investors » Corporate Information » Corporate Profile

Corporate Profile



Investor Tools

  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Tearsheet
  • Mobile IR Site
  • Social Media Sharing
  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Tearsheet
  • Mobile IR Site
  • Social Media Sharing

Stock Quote

  • NASDAQCNDO
  • Market Value ($M)133.06
  • Change ($)0.07
  • Change (%)1.82
  • Volume1,037,501
  • Stock Quote ($)3.92
As of April 1, 2015 - Minimum 20 minute delay.

Coronado Biosciences is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. As part of its growth strategy, the company is leveraging its biopharmaceutical business and drug development expertise to acquire rights to innovative pharmaceutical and biotechnology products and technologies, using a variety of approaches including, but not limited to, licensing, partnerships, joint ventures, and/or public and private spin-outs.

Contact Information

Coronado Biosciences, Inc.
24 New England Executive Park
Suite 105
Burlington, MA 01803
Phone: (781) 652-4500
Fax: (781) 652-4545
info@coronadobio.com

Investor Relations
Lucy Lu, M.D., EVP & CFO
ir@coronadobio.com
(781) 652-4525



All Releases